Results 51 to 60 of about 2,876 (183)

Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER–Medicare analysis

Cancer, Volume 131, Issue 24, 15 December 2025.
Abstract Background Clinical trials (CTs) are essential for expanding treatment options across hematologic malignancies (HM) and providing access to novel treatments. However, older adults with HM are often underrepresented in CTs, and a national‐level evaluation of factors influencing their participation is lacking.
Inna Y. Gong, Mark J. Soto, Bahar Rafinejad‐Farahani, Joseph M. Unger, Rena M. Conti, Carmen E. Guerra, Amit Oza, Meredith Rosenthal, Danielle Rodin   +8 more
wiley   +1 more source

The role of surgery in primary central nervous system lymphomas

Arquivos de Neuro-Psiquiatria
Background Primary central nervous system lymphomas (PCNSL) are infrequent. The traditional treatment of choice is chemotherapy. Complete resections have generally not been recommended, because of the risk of permanent central nervous system deficits ...
Juan Francisco Villalonga, Lucas Alessandro, Mauricio Franco Farez, Rubén Mormandi, Andrés Cervio, Santiago Condomí Alcorta, Alejandro Muggeri   +6 more
doaj   +1 more source

Proteinograma sérico de cães sadios e com linfoma obtido por eletroforese em gel de poliacrilamida (SDS-PAGE) Serum protein concentrations in healthy dogs and dogs with lymphoma by means of sodium dodecil sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)

Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2009
Foram avaliadas amostras de soro sanguíneo de 10 cães sadios e de 12 com linfoma, utilizando-se a eletroforese em gel de poliacrilamida contendo dodecil sulfato de sódio.
S.G. Calazans, C.R. Daleck, J.J. Fagliari, C.F. Repetti, A.B. De Nardi, J.H.T. Castro, S.C. Fernandes, J.R.F. César, S.M. Rodigheri   +8 more
doaj   +1 more source

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma

American Journal of Hematology, Volume 100, Issue 9, Page 1486-1501, September 2025.
ABSTRACT Nodal follicular helper T‐cell (T FH) lymphoma of the angioimmunoblastic (AITL) subtype has a dismal prognosis. Using whole‐exome sequencing (n = 124), transcriptomic (n = 78), and methylation (n = 40) analysis, we identified recurrent mutations in known epigenetic drivers (TET2, DNMT3A, IDH2 R172 ) and novel ones (TET3, KMT2D).
Alyssa Bouska, Weiwei Zhang, Sunandini Sharma, Harald Holte, Rauf A. Shah, Waseem G. Lone, Mahfuza Afroz Soma, Ruimeng Yang, Xuxiang Liu, Syed Mehmood, Ravneet Singh Chawla, Luca Vincenzo Cappelli, Danilo Fiore, Qiang Gong, Tayla B. Heavican‐Foral, Jeffrey J. Cannatella, Catalina Amador, Aiza Arif, Lynette M. Smith, Soon Thye Lim, Choon Kiat Ong, Andrew L. Feldman, Ming‐Qing Du, Anamarija M. Perry, Laurence de Leval, Timothy C. Greiner, Kai Fu, Gunhild Trøen, Daniel Vodák, Sigve Nakken, Jan Delabie, David Weinstock, Stefano Pileri, Antonella Laginestra, KyeongJin Kim, Utpal Pajvani, Julie M. Vose, Dennis D. Weisenburger, Steven M. Horwitz, Sandeep Dave, Joseph Khoury, Giorgio Inghirami, Wing C. Chan, Javeed Iqbal   +43 more
wiley   +1 more source

Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

International Journal of Cancer, Volume 157, Issue 3, Page 480-489, 1 August 2025.
What's new? In this prospective study, the authors evaluated the discrimination capacity of 92 cancer‐related proteins as potential early detection biomarkers for endometrial cancer using blood samples from two large‐scale European population cohorts (EPIC and Janus).
Victoria Cooley, Renée Turzanski Fortner, Trasias Mukama, Sabine Naudin, Valeria Pala, Laure Dossus, Inger T. Gram, Karina Standahl Olsen, Maria‐Jose Sánchez, Pernilla Israelsson, Naomi Allen, Hilde Langseth, Rudolf Kaaks   +12 more
wiley   +1 more source

A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry

HemaSphere, Volume 10, Issue 2, February 2026.
Noemí Puig, Cristina Agulló, Bruno Paiva, María‐Teresa Cedena, Laura Rosiñol, Teresa Contreras, Joaquín Martínez‐López, Albert Oriol, María‐Jesús Blanchard, Rafael Ríos‐Tamayo, Anna Sureda, Sunil Lakhwani, Javier de la Rubia, Valentín Cabañas, Felipe de Arriba, Miguel Paricio, María‐Belén Iñigo, Verónica González‐Calle, Enrique M. Ocio, Sergio Castro, Joan Bargay, Joan Bladé, Jesús F. San Miguel, Juan‐José Lahuerta, María V. Mateos   +24 more
wiley   +1 more source

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

Molecular Oncology, Volume 19, Issue 6, Page 1687-1706, June 2025.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy, Heather Fairfield, Victoria E. DeMambro, Samaa Fadel, Carlos A. Gartner, Michelle Karam, Christian Potts, Princess Rodriguez, Ya‐Wei Qiang, Habib Hamidi, Xiangnan Guan, Calvin P. H. Vary, Michaela R. Reagan   +12 more
wiley   +1 more source

Los linfomas

Oncología, 2022
Los linfomas son proliferaciones malignas de linfocitos B o T. Identifican dos tipos de neoplasias, la enfermedad de Hodgkin (EH) y los linfomas no Hodgkin (LNH). Durante las últimas décadas se han hecho importantes progresos en la compresión de sus patogénesis, la cual está ritmada por transolcaciones cromosómicas que se presentan en el desarrollo de ...
openaire   +1 more source

Linfoma Conjuntival

Anales de la Facultad de Medicina, 2014
Se presenta un caso de linfoma de células B limitado a la conjuntiva del ojo izquierdo tratado con radioterapia local.
José Avendaño Valdez, Mercedes Silva
openaire   +2 more sources

Advancing Mantle Cell Lymphoma Risk Assessment: Navigating a Moving Target

Hematological Oncology, Volume 43, Issue S2, June 2025.
ABSTRACT Mantle cell lymphoma (MCL) is a B‐cell malignancy characterized by t(11;14)(q13;q32) translocation and heterogeneous clinical behavior. Advances in risk stratification enabled the distinction of conventional MCL (cMCL) from non‐nodal MCL (nnMCL) subtypes, which presents with distinct biological and clinical features.
Simone Ferrero, Simone Ragaini
wiley   +1 more source